Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

4.37
Delayed Data
As of Dec 06
 +0.17 / +4.05%
Today’s Change
3.78
Today|||52-Week Range
10.95
-59.50%
Year-to-Date

Today’s Trading

Previous close4.20
Today’s open4.31
Day’s range4.19 - 4.40
Volume2,038,732
Average volume (3 months)1,859,258
Market cap$574.1M
Dividend yield--
Data as of 12/06/2016

Growth & Valuation

Earnings growth (last year)+94.29%
Earnings growth (this year)-1,408.61%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales20.49
Price/Book1.28

Competitors

 Today’s
change
Today’s
% change
RETAReata Pharmaceutical...-1.53-5.93%
FLXNFlexion Therapeutics...+0.57+3.11%
LOXOLoxo Oncology Inc+0.09+0.34%
CLLSCellectis SA+0.07+0.41%
Data as of 12/06/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$66.1M
Annual profit (last year)-$5.0M
Net profit margin-7.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Executive VP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts


Search for Jobs